The role of MRI viability testing to decide on percutaneous coronary interventions strategies of complex coronary artery disease.

The role of MRI viability testing to decide on percutaneous coronary interventions strategies of complex coronary artery disease. - VICAD

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30200

Enrollment

100

Registered

2006-08-22

Start date

2006-08-22

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myocardial infarction viability

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: chronic coronairy arterie disease ejection fraction

Exclusion criteria

Exclusion criteria: (1) contraindications for MRI, pacemaker, cochlea implant (2) pregnancy (3) Inability to breath hold for up to 15 seconds (4) Inability to give reliable informed consent (5) known claustrophobia, (6) unstable coronary artery disease, (7) known allergy to contrast material.

Design outcomes

Primary

Measure	Time frame
regional wall motion abnormalities	—

Secondary

Measure	Time frame
end-diastolic volume end-systolic volume ejection fraction	—

Countries

Netherlands

Outcome results